Last reviewed · How we verify

NCT03295682: CONNECT

Registry in Patients With Thoracoabdominal Aneurysms

Completed Last updated 17 February 2026
What this trial tests

trial testing Endovascular thoracoabdominal aneurysm repair in Thoracoabdominal Aneurysm in 47 participants. Completed in 30 August 2024.

Timeline
11 September 2017
Primary endpoint
31 May 2022
30 August 2024

Quick facts

Lead sponsorJOTEC GmbH
StatusCompleted
Study typeOBSERVATIONAL
Enrollment47
Start date11 September 2017
Primary completion31 May 2022
Estimated completion30 August 2024
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

JOTEC GmbH

Who can join

18 and older, any sex, with Thoracoabdominal Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study patients will be observed, who receive a multi-branch stent graft tailored to the patients anatomy for the endovascular treatment of a thoracoabdominal aortic aneurysm Crawford type I, II, III, IV or V. The objective of this study is to evaluate clinical and technical success as well as safety and feasibility of the multi-branch stent graft Systems used in endovascular treatment of thoracoabdominal aortic aneurysms that cannot be treated with commercially available devices. Primary endpoint of this study is the rate of patients with stable or decreasing aneurysm size at 12 months follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other JOTEC GmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03295682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing